OrthoAccel Technologies announces that the company's groundbreaking AcceleDent device is now available in 2,000 orthodontic locations across the US.

An FDA-cleared medical device that works in conjunction with orthodontics, AcceleDent speeds up treatment by as much as 50% t with 20 minutes of daily use.

As one of the first major orthodontic innovations in more than 15 years, the distinct nature of AcceleDent’s technology has been solidified with two new patents for OrthoAccel issued by the United States Patent and Trademark Office. The patents are related to the company’s proprietary SoftPulse Technology.

In addition to its latest growth milestones, the company reports that in a recent independent study, 100 percent of patients surveyed say that AcceleDent is easy to use and that they were satisfied with their experience using the technology.

"More patients are asking their orthodontists about accelerated treatment with AcceleDent, and more orthodontists are eager to offer AcceleDent because of the positive patient results," said Mike Lowe, OrthoAccel’s president and CEO.

"As the leader in accelerated orthodontics, it’s important that OrthoAccel continue to gain the trust of orthodontists from across the country. We believe the best way to do that is through helping to improve the patient experience by continually driving advances in orthodontic innovation."